🇺🇸 FDA
Patent

US 11266655

Methods and compositions for treating urea cycle disorders

granted A61KA61K31/395A61K31/416

Quick answer

US patent 11266655 (Methods and compositions for treating urea cycle disorders) held by CAMP4 Therapeutics Corporation expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAMP4 Therapeutics Corporation
Grant date
Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/395, A61K31/416, A61K31/519, A61K31/52